Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
CryoLife to Present at 37th Annual Canaccord Genuity Growth Conference
-
Xencor to Present at Upcoming Investor Conferences
-
Atara Biotherapeutics to Present at the Canaccord Genuity 37th Annual Growth Conference
-
Lipocine to Present at the Canaccord Genuity 37th Annual Growth Conference
-
T2 Biosystems to Present at the 37th Annual Canaccord Genuity Growth Conference
-
Aerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference
-
Akoustis® Technologies’ CEO to Present at Canaccord Genuity’s 37th Annual Growth Conference at 9:30 am EDT on August 9th
-
Seres Therapeutics to Present at the Canaccord Genuity 37th Annual Growth Conference
-
LSI Industries Inc. to Present at the Canaccord Genuity 2017 Growth Conference
-
Quantenna to Present at Upcoming Investor Conferences
-
Carmanah Announces Completion of Sale of Off-Grid Power (Go Power!) Business
-
Nanotech to Present at the 2017 Canaccord Genuity 37th Annual Growth Conference
-
AeroVironment, Inc. to Present at the Jefferies 2017 Industrials Conference and Canaccord Genuity’s 37th Annual Growth Conference
-
ImmunoGen Announces Webcast of Presentation at the Canaccord Genuity Growth Conference
-
Teladoc to Participate in Upcoming Investor Conferences
-
LeMaitre Vascular to Present at Upcoming Investor Conferences
-
Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th
-
U.S. Auto Parts to Present at the 37th Annual Canaccord Genuity Growth Conference on August 10, 2017
-
UPDATE: Canaccord Genuity Upgrades Rockwell Collins (COL) to Buy
-
Adesto Technologies to Present at the Canaccord Genuity Conference on August 9
-
Kite to Present at August 2017 Investor Conference
-
Black Diamond, Inc. to Present at the 37th Annual Canaccord Genuity Growth Conference on August 9, 2017
-
MuleSoft to Present at the Canaccord Genuity 37th Annual Growth Conference
-
iCAD to Present at the Canaccord Genuity 37th Annual Growth Conference
-
Oncolytics Biotech® Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference
-
pSivida to Present at Canaccord Genuity Growth Conference on August 10, 2017
-
Mitek to Present at Canaccord Genuity Growth Conference in Boston on August 9, 2017
-
Lannett To Present At The Canaccord Genuity 37th Annual Growth Conference On August 9
-
Exact Sciences to participate in Canaccord Genuity Growth Conference
-
OraSure Technologies to Present at the Canaccord Genuity 37th Annual Growth Conference
-
Pandora (P) PT Lowered to $14 at Canaccord Genuity
-
CRH Medical Corporation To Present at the Canaccord Genuity Growth Conference
-
Quidel to Present at the 37th Annual Canaccord Genuity Growth Conference
-
Renewable Energy Group to Present at Upcoming Investor Conferences
-
Hologic to Webcast Presentations at Upcoming Investor Conferences
-
Lack of value fund interest could be another bad omen for Chipotle
-
GenMark Diagnostics to Attend Canaccord Genuity’s 37th Annual Growth Conference
-
Edwards Lifesciences To Present At 37th Annual Canaccord Genuity Growth Conference
-
Merit Medical to Participate at Three Conferences
-
Obalon Announces Upcoming Conference Presentation
-
Ameresco to Participate in 37th Annual Canaccord Genuity Growth Conference in Boston on August 9
-
Boston Scientific To Participate In 2017 Canaccord Genuity Growth Conference
-
Cognition Therapeutics CEO Kenneth I. Moch to Present at Canaccord Genuity Annual Growth Conference
-
Veritone to Present at the 37th Annual Canaccord Genuity Growth Conference on August 9, 2017
-
Canaccord Genuity Starts Teligent (TLGT) at Buy
-
Canaccord Genuity Starts Impax Laboratories (IPXL) at Hold
-
Canaccord Genuity Starts Aceto Corp. (ACET) at Buy
-
Canaccord Genuity Starts ANI Pharmaceuticals (ANIP) at Buy
-
pdvWireless to Present at the Canaccord Genuity 37th Annual Growth Conference
-
Woden Venture Capital Corporation: Acquistion of ACCUM Therapeutics-Qualifying Transaction-Change of Name-Consolidation-Concurrent Private Placements-Loan to the Target

